Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04162353Phase 1Recruiting
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
Multiple Myeloma in RelapsePlasmacytoid; LymphomaRefractory Multiple Myeloma
PrincipalinvestigatorStart date: 2019-07-01

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Chengdu Military General Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hongyu Zhang, MD/PhD

Peking University Shenzhen Hospital, China

Moderately Similar
3 trials

Shared therapeutic areas:

Multiple Myeloma in RelapsePlasmacytoid; LymphomaRefractory Multiple Myeloma

Worked with same sponsors:

iCAR Bio Therapeutics Ltd.iCell Gene Therapeutics+1 more
Collaborated on 1 trial
Similarity Score34%

Ajai Chari, MD

Icahn School of Medicine at Mount Sinai

Related
5 trials

Shared therapeutic areas:

Multiple Myeloma in RelapseRefractory Multiple Myeloma
Similarity Score20%

Steven D Reich, MD

Triphase Research and Development I Corp

Related
5 trials

Shared therapeutic areas:

Multiple Myeloma in RelapseRefractory Multiple Myeloma
Similarity Score20%

Jessica Sachs, MD

Cogent Biosciences, Inc.

Related
5 trials

Shared therapeutic areas:

Multiple Myeloma in RelapseRefractory Multiple Myeloma
Similarity Score20%

Jacalyn Rosenblatt, MD

Beth Israel Deaconess Medical Center

Related
9 trials

Shared therapeutic areas:

Refractory Multiple MyelomaMultiple Myeloma in Relapse
Similarity Score20%

Evanthia Galanis, MD

Alliance Foundation Trials, LLC.

Related
7 trials

Shared therapeutic areas:

Multiple Myeloma in RelapseRefractory Multiple Myeloma
Similarity Score20%

Craig Hofmeister, MD

Ohio State University

Related
4 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score10%

Sham Mailankody, MBBS

Memorial Sloan Kettering Cancer Center

Related
5 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score10%

Charles Erlichman

Mayo Clinic

Related
6 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score10%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04162353Phase 1PrincipalInvestigator

BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma

Multiple Myeloma in RelapsePlasmacytoid; LymphomaRefractory Multiple Myeloma
Recruiting

All 1 trials loaded